Immunotherapy has revolutionized cancer treatment in the clinic, but without benefiting every patient.
This could lead to new approaches to treat cancer patients resistant to checkpoint blockade immunotherapy.
candidate at the UMSOM Center for Immunology and Carcinogenesis Research and lead author of the study.
Scientists at the University of Copenhagen have identified a new hard-to-detect biomarker of Alzheimer’s disease. The new markers are specific against a very specific protein, TREM2, that is known to play an important role in establishing neuronal connections and in protecting the brain against age-related neurodegeneration. The study has been published in Neuron. Alzheimer’s disease…
